| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cce74ae91129e276612f5855529149a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55594
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4354
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0003 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00 |
| filingDate |
2012-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea5ac3e833017c414d4ecb7340cebda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cfe987c22aa909fbfbbe39860356704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae6171408d172798bd4e174f3edef36e |
| publicationDate |
2014-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2453391-A1 |
| titleOfInvention |
Recombinant Haemonchus contortus protein and its application for the production of a vaccine against hemoncosis. |
| abstract |
Recombinant protein of Haemonchus contortus and its application for the production of a vaccine against hemoncosis. # A recombinant protein (rHc23) of H. contortus has been obtained after verifying that the native protein Hc23, 23kDa molecular weight Originally from the soluble extract of adults of the hematophagous nematode H. contortus has shown immunoprotective capacity in young sheep of 5 months of age against the most important trichostrongilidosis (hemoncosis) from an economic and pathological point of view. Hc23 protein, obtaining the amino acid and genomic sequences thereof, allowing, by molecular biology techniques, recombinant DNA, the production of a stable protein, rHc23. Its use in immunogenic compositions that include as an adjuvant the combination of inactivated Propionibacterium acnes + E. coli lipopolysaccharides has shown a high degree of protection in animals (> 85% protection). |
| priorityDate |
2012-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |